These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine. Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R Headache; 2011; 51(7):1078-86. PubMed ID: 21631494 [TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM; Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098 [TBL] [Abstract][Full Text] [Related]
5. Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG). Bayer O; Adrion C; Al Tawil A; Mansmann U; Strupp M; Trials; 2019 Dec; 20(1):813. PubMed ID: 31888723 [TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH; Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial. Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
9. Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial. Rahnama P; Montazeri A; Huseini HF; Kianbakht S; Naseri M BMC Complement Altern Med; 2012 Jul; 12():92. PubMed ID: 22781186 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial. Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835 [TBL] [Abstract][Full Text] [Related]
11. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial. Dodick DW; Silberstein SD; Bigal ME; Yeung PP; Goadsby PJ; Blankenbiller T; Grozinski-Wolff M; Yang R; Ma Y; Aycardi E JAMA; 2018 May; 319(19):1999-2008. PubMed ID: 29800211 [TBL] [Abstract][Full Text] [Related]
13. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ; Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971 [TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of ginger (Zingiber officinale) rhizome extract in outpatients with COVID-19: A randomized double-blind placebo-control clinical trial. Ameri A; Farashahinejad M; Davoodian P; Safa O; Hassaniazad M; Parsaii M; Heidari B; Hassanipour S; Akhlaghi B; Fathalipour M Medicine (Baltimore); 2024 May; 103(22):e38289. PubMed ID: 39259072 [TBL] [Abstract][Full Text] [Related]
15. Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial. Wilkinson D; Ade KK; Rogers LL; Attix DK; Kuchibhatla M; Slade MD; Smith LL; Poynter KP; Laskowitz DT; Freeman MC; Hoffer ME; Saper JR; Scott DL; Sakel M; Calhoun AH; Black RD Headache; 2017 Jul; 57(7):1065-1087. PubMed ID: 28656612 [TBL] [Abstract][Full Text] [Related]
16. Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study. Dilli E; Halker R; Vargas B; Hentz J; Radam T; Rogers R; Dodick D Cephalalgia; 2015 Oct; 35(11):959-68. PubMed ID: 25505035 [TBL] [Abstract][Full Text] [Related]
17. Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States. Woolley JM; Bonafede MM; Maiese BA; Lenz RA Headache; 2017 Oct; 57(9):1399-1408. PubMed ID: 28842990 [TBL] [Abstract][Full Text] [Related]
18. Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial. Ferrari MD; Diener HC; Ning X; Galic M; Cohen JM; Yang R; Mueller M; Ahn AH; Schwartz YC; Grozinski-Wolff M; Janka L; Ashina M Lancet; 2019 Sep; 394(10203):1030-1040. PubMed ID: 31427046 [TBL] [Abstract][Full Text] [Related]
19. Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine. Maghbooli M; Golipour F; Moghimi Esfandabadi A; Yousefi M Phytother Res; 2014 Mar; 28(3):412-5. PubMed ID: 23657930 [TBL] [Abstract][Full Text] [Related]